read more COTC031: Safety evaluation of three forms of a novel immunotherapy agent in dogs with cancer devonlea | March 14, 2024
read more COTC027: Preclinical Comparison of Two Hypomethylating Nucleosides in Tumor-Bearing Dogs jicox | March 17, 2022